These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1404787)

  • 1. The self-reporting of cocaine use.
    Gleason JM; Barnum DT
    JAMA; 1992 Nov; 268(17):2373; author reply 2375-6. PubMed ID: 1404787
    [No Abstract]   [Full Text] [Related]  

  • 2. The self-reporting of cocaine use.
    Rich J; Bigby J
    JAMA; 1992 Nov; 268(17):2375-6. PubMed ID: 1404790
    [No Abstract]   [Full Text] [Related]  

  • 3. The self-reporting of cocaine use.
    Watters JK; Needle R; Brown BS; Weatherby N; Booth R; Williams M
    JAMA; 1992 Nov; 268(17):2374-5; author reply 2375-6. PubMed ID: 1404789
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation between self-reported cocaine use and urine toxicology in an inner-city prenatal population.
    Lindsay MK; Carmichael S; Peterson H; Risby J; Williams H; Klein L
    J Natl Med Assoc; 1997 Jan; 89(1):57-60. PubMed ID: 9002417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 800-COCAINE helpline: survey of 500 callers.
    Washton AM; Gold MS; Pottash AC
    NIDA Res Monogr; 1984; 55():224-30. PubMed ID: 6443383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency department presentations with suspected acute coronary syndrome--frequency of self-reported cocaine use.
    Bishop CR; Dargan PI; Greene SL; Garnham F; Wood DM
    Eur J Emerg Med; 2010 Jun; 17(3):164-6. PubMed ID: 19584737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine use during pregnancy: prevalence and correlates.
    Frank DA; Zuckerman BS; Amaro H; Aboagye K; Bauchner H; Cabral H; Fried L; Hingson R; Kayne H; Levenson SM
    Pediatrics; 1988 Dec; 82(6):888-95. PubMed ID: 3186380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the prevalence of drug use from self-reports in a cohort for which biologic data are available for a subsample.
    Poole WK; Flynn PM; Rao AV; Cooley PC
    Am J Epidemiol; 1996 Aug; 144(4):413-20. PubMed ID: 8712199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of self-reporting of marijuana and cocaine use among pregnant adolescents.
    Zuckerman B; Amaro H; Cabral H
    J Pediatr; 1989 Nov; 115(5 Pt 1):812-5. PubMed ID: 2809916
    [No Abstract]   [Full Text] [Related]  

  • 10. Reducing bias in telephone survey estimates of the prevalence of drug use: a randomized trial of telephone audio-CASI.
    Turner CF; Villarroel MA; Rogers SM; Eggleston E; Ganapathi L; Roman AM; Al-Tayyib A
    Addiction; 2005 Oct; 100(10):1432-44. PubMed ID: 16185205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting bias and self-reported drug use.
    Macleod J; Hickman M; Smith GD
    Addiction; 2005 Apr; 100(4):562-3. PubMed ID: 15784073
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of positive urine drug screens in a prenatal clinic: correlation with patients' self-report of drug use.
    Ashling K; Gross AH; Coghlin DT; Sweeney PJ
    R I Med; 1994 Nov; 77(11):371-3. PubMed ID: 7812052
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictors of disclosure of continued cocaine use.
    Tassiopoulos K; Bernstein J; Heeren T; Levenson S; Hingson R; Bernstein E
    Addict Behav; 2006 Jan; 31(1):80-9. PubMed ID: 15908136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The validity of self-reported cocaine use in two high-risk populations.
    Magura S; Kang SY
    NIDA Res Monogr; 1997; 167():227-46. PubMed ID: 9243564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users.
    Uosukainen H; Tacke U; Winstock AR
    Int J Drug Policy; 2015 Jan; 26(1):78-83. PubMed ID: 25107829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-wide estimation of illicit drug use in delivering women: prevalence, demographics, and associated risk factors.
    Vaughn AJ; Carzoli RP; Sanchez-Ramos L; Murphy S; Khan N; Chiu T
    Obstet Gynecol; 1993 Jul; 82(1):92-6. PubMed ID: 8515933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric and substance-use comorbidities associated with lifetime crack cocaine use in young adults in the general population.
    Narvaez JC; Jansen K; Pinheiro RT; Kapczinski F; Silva RA; Pechansky F; Magalhães PV
    Compr Psychiatry; 2014 Aug; 55(6):1369-76. PubMed ID: 24933652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of use of cocaine and other substances in an obstetric population.
    Matera C; Warren WB; Moomjy M; Fink DJ; Fox HE
    Am J Obstet Gynecol; 1990 Sep; 163(3):797-801. PubMed ID: 2403158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and self-reported consequences of cocaine use.
    Trinkoff AM; Ritter CJ; Anthony JC
    NIDA Res Monogr; 1989; 95():329. PubMed ID: 2640982
    [No Abstract]   [Full Text] [Related]  

  • 20. Discussion of "Validity Testing of Commercial Urine Cocaine Metabolite Assays: Parts I and II".
    Spiehler V; Wilson H; el Shami S
    J Forensic Sci; 1990 Mar; 35(2):230-2. PubMed ID: 2329327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.